Skip to content
Clinical Trials – home
Verifiedinfo

Vaestra Goetalandsregionen

Sweden Domkyrkofoers. I, Bergslagsgatan 2, Domkyrkofoers. I Goteborg, 411 04 Gothenburg, Sweden

  • 1 trial recruiting
  • Osteoarthritis · Attention deficit hyperactivity disorder
  • Adults and children

About Specializations

Vaestra Goetalandsregionen in Gothenburg, Sweden specialises in clinical trials of conditions such as Osteoarthritis, Attention deficit hyperactivity disorder, and other specialisations. This site conducts important research.

Main research areas of the site

Psychiatry and Psychology: Behavioral Disciplines and Activities

At Vastraa Goetalandsregionen, the Dep of Pediatrics is contributing to clinical research in Psychiatry and Psychology with a focus on behavioral disciplines and related mental health conditions in children, adolescents, and adults. The studies are centered on evaluating new or existing treatments and understanding their effects on symptoms and day-to-day functioning.

  • Research in ADHD is examining the safety and effectiveness of treatment options for children and adolescents who cannot use stimulant medicines.
  • One key goal is to better understand how therapy may support attention, psychomotor speed, and overall cognitive performance.
  • The site is also involved in work on schizophrenia spectrum disorder, looking at whether an immune-based treatment can improve psychiatric symptoms.

This area of research reflects a strong interest in improving care for mental disorders through studies that assess treatment benefit, symptom change, and longer-term patient outcomes.

Mental Disorders: ADHD and Schizophrenia Spectrum Disorder

The clinical trials at this hospital/clinic in Goteborg are focused on two major mental health conditions: attention-deficit/hyperactivity disorder and schizophrenia spectrum disorder. The research aims to compare treatment options, monitor safety, and explore whether therapies can improve everyday functioning and clinical symptoms.

  • In ADHD, the trials are testing treatment effectiveness and long-term safety in younger patients.
  • In schizophrenia spectrum disorder, the studies are evaluating whether a targeted therapy may reduce psychotic symptoms more effectively than placebo.
  • These projects support better treatment selection for patients with complex psychiatric needs.

Overall, the research combines psychiatric care and clinical evaluation to help determine which approaches may offer the greatest benefit for patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Domkyrkofoers. I, Bergslagsgatan 2, Domkyrkofoers. I Goteborg411 04 GothenburgSweden
Recruiting now
1 trial
Conditions studied
2
Partner status
Verified

More sites in GothenburgSweden

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Paracetamol
  • Sponsor:Vaestra Goetalandsregionen
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Guanfacine
  • Sponsor:Takeda Development Center Americas Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.